Related Experiment Video
Updated: Oct 14, 2025

Measuring Lactase Enzymatic Activity in the Teaching Lab
Published on: August 6, 2018
Congenital Glucose-Galactose Malabsorption: A Case With a Novel SLC5A1 Mutation in a Saudi Infant
Loujen O Alamoudi1, Albaraa T Alfaraidi1, Samiyah S Althagafi2
1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Centre, King Abdulaziz Medical City, Ministry of the National Guard - Health Affairs, Jeddah, SAU.
Insights
Congenital glucose-galactose malabsorption (GGM) is a rare disorder causing severe diarrhea. Early diagnosis and fructose-based formula are crucial for managing this life-threatening condition in infants.
Area of Science:
- Metabolic disorders
- Pediatric gastroenterology
- Genetic diseases
Background:
- Congenital glucose-galactose malabsorption (GGM) is an extremely rare autosomal-recessive metabolic disorder.
- Characterized by intractable diarrhea and severe dehydration, GGM can be life-threatening if not treated.
- The rarity of GGM makes it a diagnostic challenge for clinicians.
Observation:
- A seven-month-old Saudi infant presented with recurrent severe watery diarrhea and failure to thrive.
- Standard treatments were ineffective for the infant's symptoms.
- The infant exhibited symptoms despite appropriate initial medical care.
Findings:
- Molecular testing revealed a compound heterozygous variant in the SLC5A1 gene.
- This genetic finding confirmed the diagnosis of congenital glucose-galactose malabsorption.
- The patient's condition was linked to a specific genetic mutation.
Implications:
- Highlights the importance of considering rare diseases like GGM in differential diagnoses.
- Emphasizes the need for early diagnosis and timely management to prevent severe complications.
- Fructose-based formulae are an effective treatment for GGM, improving infant outcomes.
Abstract:
While only a few hundred cases have been reported in pediatrics, congenital glucose-galactose malabsorption (GGM) is an extremely rare autosomal-recessive metabolic disorder that is characterized by intractable diarrhea and severe dehydration, which can be life-threatening if not treated appropriately. Due to the rarity of the disease, it is challenging to consider GGM as an initial diagnosis for most clinicians. We report the clinical and diagnostic course of a seven-month-old Saudi infant who presented with severe recurrent episodes of watery diarrhea and failure to thrive in early infancy despite standard treatment. Molecular testing identified that our patient had a compound heterozygous variant in SLC5A1. Fructose-based formulae have been proven to be effective in treating GGM. This case highlights the importance of early diagnosis and timely management to prevent serious complications of undiagnosed GGM.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Glucose Absorption Into the Small Intestine
Carbohydrate Absorption
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
Secondary Active Transport
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

